Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L
Service des maladies infectieuses, hôpital Bretonneau, université François-Rabelais, 37000 Tours, France.
Service de médecine aiguë spécialisée, hôpital R.-Poincaré, université de Versailles, 92380 Garches, France.
Med Mal Infect. 2016 Sep;46(6):294-9. doi: 10.1016/j.medmal.2016.02.010. Epub 2016 Jun 16.
Urinary tract infections (UTIs) are a major recurrent problem for spinal cord injury (SCI) patients. Repeated antibiotic treatments contribute to the emergence of multidrug-resistant bacteria (MDRB). We evaluated the use of weekly oral cycling antibiotics (WOCA) in the prevention of UTIs over a mean follow-up period of 53 months (median follow-up period: 57 months) and analyzed the risk of MDRB emergence.
We conducted a cross-sectional study of adult SCI patients with neurogenic bladder who were receiving the WOCA regimen.
We included 50 patients, mainly men (60%), with a mean age of 51±13.5 years. Overall, 66% of patients had been paraplegic or tetraplegic for 19.4±14.3 years; 92% underwent intermittent catheterization; and 36% had no postvoid residual. The number of febrile and non-febrile UTIs significantly reduced after WOCA initiation (9.45 non-febrile UTIs before WOCA initiation vs. 1.57 after; 2.25 febrile UTIs before WOCA initiation vs. 0.18 after; P=0.0001). Only one adverse event was reported during the follow-up period. The number of MDRB-colonized patients decreased from 9/50 to 4/50 during the follow-up period.
WOCA is an effective and safe strategy to prevent UTIs in SCI patients with neurogenic bladder. WOCA does not lead to the emergence of MDRB resistance and even seems to reduce MDRB carriage.
尿路感染(UTIs)是脊髓损伤(SCI)患者反复出现的主要问题。反复使用抗生素治疗会导致多重耐药菌(MDRB)的出现。我们评估了在平均53个月(中位随访期:57个月)的随访期内使用每周口服循环抗生素(WOCA)预防尿路感染的效果,并分析了出现MDRB的风险。
我们对接受WOCA方案的成年神经源性膀胱SCI患者进行了一项横断面研究。
我们纳入了50例患者,主要为男性(60%),平均年龄为51±13.5岁。总体而言,66%的患者截瘫或四肢瘫19.4±14.3年;92%的患者接受间歇性导尿;36%的患者无残余尿量。开始使用WOCA后,发热性和非发热性UTIs的数量显著减少(开始使用WOCA前非发热性UTIs为9.45次,之后为1.57次;开始使用WOCA前发热性UTIs为2.25次,之后为0.18次;P=0.0001)。随访期间仅报告了1例不良事件。随访期间,MDRB定植患者的数量从9/50降至4/50。
WOCA是预防神经源性膀胱SCI患者尿路感染的一种有效且安全的策略。WOCA不会导致MDRB耐药的出现,甚至似乎能减少MDRB的携带。